Replimune Group, Inc.

REPL·NASDAQ·$5.91Share Price as of 11/2·$393MMarket Cap as of 11/2

Financials

10-QQ2 ended 09/30/2610/28/26 10-QQ1 ended 06/30/2608/14/26 10-KFY 202606/29/26 10-QQ3 ended 12/31/2502/03/26 10-QQ2 ended 09/30/2511/06/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report09/16/26 8-KCurrent report08/14/26 8-K/ACurrent report (amended)08/11/26 8-KCurrent report08/10/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration08/14/26 424B5Prospectus supplement08/10/26 S-3/AShelf registration (amended)07/24/26 S-8Registration of securities for employees06/29/26 S-3/AShelf registration (amended)11/06/25

Proxies

DEF 14ADefinitive proxy07/29/26 DEFA14AAdditional proxy materials07/29/26 PRE 14APreliminary proxy07/13/26 DEF 14ADefinitive proxy07/25/25 DEFA14AAdditional proxy materials07/25/25

Ownership

144Proposed sale of securities10/30/26 144Proposed sale of securities10/28/26 Form 4Insider transaction08/24/26 Form 4Insider transaction08/19/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

ARSAnnual report to shareholders07/29/26 EFFECTRequest for effectiveness07/29/26 ARSAnnual report to shareholders07/25/25 UPLOADLetter from the SEC06/02/25 UPLOADLetter from the SEC02/20/25